SARS Revisited: The Challenge of Controlling Emerging Infectious Diseases at the Local ..... Addressing New Emerging Infectious Disease Threats and.
pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother. 2002;50(suppl ...
Feb 22, 2011 - Global tuberculosis control 2010. http:// whqlibdoc.who.int/publications/2010/9789241564069_eng.pdf. ...... AAOS = American Association of Orthopedic Surgeons; ADA = Ameri- can Dental Association; ANP = acute ...... intolerance to a co
Medical informed consent should be an exchange of ideas that buttresses the patient-physician relationship. The consent process should be the foundation of the fiduciary relationship between a patient and a physician. ... their states' statutory laws
Hypnosis became popular as a treatment for medical conditions in the late 1700s when ..... pin pricks and laser-induced burn pain.13 Hypnosis was associated with a .... successful remission, whereas low expectation for wart regression had a ...
Mayo Clin Proc, October 2003, Vol 78. 1276 Anemia in Adults. Hemolytic anemias. Test. All types. Intravascular Extravascular. Reticulocyte count. Increased .... 1278 Anemia in Adults. Figure 2. Evaluation of extravascular hemolysis. G6PD = glucose-6-
Liver Disease (MELD) score; Lille score; age, .... alcoholic hepatitis score were not assessed ...... Verma, PhD, Sarah Wilder, RN, BSN, Amy Olofson, RN,.
shocked the world with the first human to human heart transplant. ... Questions Remain on. Routine ..... to answer the questions of clinical efficacy and safety.
(hallux rigidus). An orthotic with a rigid, finger-like projection under the big toe prevents painful movement of the toe. Also helpful is a traditional rocker bottom ...
energy you burn. Overeating and lack of physical activity are the main reasons why people pack on excess pounds. However, aging also can contribute to weight gain as well as to an increase in body fat. That's because as you age, you gradually lose mu
Mar 8, 2014 - B, Axial T2 FLAIR image of a 6-year-old girl with acute dissemi- ... children must have frequent lab evaluations. Other common side effects include ..... Clinic in Minnesota: Phone: 800-323-2688 (toll-free) or 507-284-2509.
resected. A posterior annuloplasty is then performed with ... most frequent finding is tricuspid regurgitation secondary ... The DeVega technique is a running.
nomas â whose cells typically look and act .... Health Letter, Subscription Services, P.O. Box 9302,. Big Sandy, TX ... Barium enema (colon X-ray). â This test ... Like a barium enema, it involves radiation ..... wash your hands with soap and.
Nov 10, 2011 - Current Trends in the Practice of Medicine. Vol. 27, No. 5, 2011. INSIDE THIS ISSUE. 2Enhanced Recovery. Pathway: Rethinking. Pre- and Postoperative. Surgical Care for. Colorectal Patients ..... titioners, internists, general practitio
Wetjen occasionally reviews the medical history,. MRI scans, and videos sent by parents who are considering .... pathologic finding in this class of disorders is the presence of ubiquitin-positive neuronal and glial inclusions in ... officials in Ind
procedure is available at no additional charge to all female patients ... cameras mounted on a modified mammography unit. ... In 1968, Bentall and De Bono de-.
American Association of Clinical Endocrinolo- gists and the Mayo Clinic Division of Endocri- nology, Diabetes, Metabolism, and Nutrition. Hossein Gharib, MD, of the Division of Endo- crinology, Diabetes, Metabolism, and Nutrition at Mayo Clinic in Mi
re-engineering strategies that rely on getting closer to what the consumer is thinking and feeling. Design and innovation firms suggested empathy as a pathway to improved customer services. Renaissance Health even called on Disney Imagineers to help
mune system launches an attack on the body's own cells or ... prior to starting TNF inhibitor treat- ment. ... abatacept (Orencia); tocilizumab (Actemra); anakinra ...
Focus on PSA Screening for Prostate Cancer Vol. 28 Supplement ..... 3.0T MR-guided laser ablation of a prostate cancer recurrence in the post- surgical prostate ...
Dec 22, 2011 - Comorbidities. Neurologic Surgery and Clinical Neurology News ... treatment was often delayed because the cause .... or subdural hygroma.
Contact: 800-323-2688 or e-mail: [email protected] Update in EEG, EMG, and Clinical Neurophysiology. February 24 - March 2, 2013. Amelia Island, Florida.
5Robotic Thyroidectomy. 6Diabetes and Cancer. Endocrinology News from Mayo Clinic. Vol. 5, No. 3, 2010. EndocrinologyUpdate. In 1984, the adrenal pathologic findings in. 4 Mayo Clinic cases of Cushing syndrome led to characterization of a unique diso
Psychiatric adverse effects during systemic corticosteroid ther- apy are common. Two large meta-analyses found that severe reac- tions occurred in nearly 6% of patients, and mild to moderate reactions occurred in about 28%. Although disturbances of m
Reproduced with permission from Mayo Clinic Proceedings.
Mayo Clinic Proceedings
June 1999 Volume 74 Number 6
Gastric Stromal Sarcoma, Pulmonary Chondroma, and Extra-adrenal Paraganglioma (Carney Triad): Natural History, Adrenocortical Component, and Possible Familial Occurrence J. AIDAN CARNEY, MD, PHD
• Objective: To investigate the natural history of the triad of gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma, a rare syndrome of unknown cause primarily affecting young women. • Methods: Mayo Clinic records, the world literature, and the author’s files were searched for patients with all or 2 of the 3 tumors. • Results: Seventy-nine patients, 67 women and 12 men, were identified, 17 (22%) with the 3 tumors and 62 (78%) with 2 tumors. Forty-two (53%) had gastric and pulmonary tumors, the most common combination. The longest interval between detection of the first and second components was 26 years (mean, 8.4 years; median, 6 years). Follow-up ranged from 1 year to 49 years (mean, 20.6 years; median, 20 years). Sixty-four patients (81%) were alive, 19 (24%) apparently free of disease and 45 (57%)
with residual or metastatic tumors. Thirty-two patients (41%) had had 1 or more local recurrences of the gastric sarcoma; the longest interval to first recurrence was 36 years. Twenty-one survivors (27%) had hepatic metastatic gastric sarcoma with follow-up of 1 year to 25 years (mean, 9.3 years; median, 7 years). Fifteen patients (19%) were dead, 10 (13%) of whom died of the disorder. Ten patients (13%) had nonfunctioning adrenocortical tumors. Two patients each had a sibling with 1 component of the triad. • Conclusions: The triad is a chronic, persistent, and indolent disease. Benign adrenocortical tumors are a component of the condition. The disorder may be familial. Mayo Clin Proc. 1999;74:543-552 131
n 1977, Carney et al1 reported the association of gastric (epithelioid) leiomyosarcoma, functioning extra-adrenal paraganglioma, and pulmonary chondroma (herein referred to as “the triad”) in 2 patients and 2 of the 3 tumors in 5 other patients, all unrelated young women. One patient2 also had a nonfunctioning adrenocortical adenoma. The tumor pattern—multifocal lesions in multiple organs in young patients—suggested an inherited disorder, but such was not found. In 1983, Carney3 reviewed findings in 24 affected patients (including 2 males), 6 of whom had the 3 tumors. The gastric neoplasm had metastasized in 8 patients, demonstrating its malignant nature, but its behavior was indolent in comparison with that of the sporadic neoplasm, an aggressive tumor, once metastasis had occurred.4 Some of the paragangliomas were nonfunctioning in the new patients,
none of whom at that time had an adrenocortical tumor. There were no familial cases. For accompanying editorial, see page 638 Since 1983, 48 additional patients have been recognized. This article reports findings in the 79 patients, provides insight into the natural history of the triad, identifies adrenocortical adenoma as a component of the disorder, and raises the possibility that the syndrome may be familial. METHODS Records of the Mayo Clinic, Rochester, Minn, the world literature, and the author’s files were searched for patients with 2 or more of the following: (1) gastric leiomyoblastoma, gastric leiomyosarcoma, gastric epithelioid leiomyosarcoma, gastric stromal tumor, gastric plexosarcoma, or gastric autonomic nerve tumor; (2) pulmonary chondroma, pulmonary hamartoma, or pulmonary osteochondroma; and (3) extra-adrenal paraganglioma or pheochromocytoma (adrenal paraganglioma). Seventy-nine cases were identified, 12 from Mayo Clinic records, 45 from the literature,5-61 and 22 from the author’s files. Clini-
From the Department of Laboratory Medicine and Pathology (emeritus member), Mayo Clinic Rochester, Rochester, Minn. Address reprint requests and correspondence to J. Aidan Carney, MD, Emeritus Staff Center, Mayo Clinic Rochester, 200 First St SW, Rochester, MN 55905. Mayo Clin Proc. 1999;74:543-552
I MIBG = radioactive iodine–metaiodobenzylguanidine
For personal use. Mass reproduce only with permission from Mayo Clinic Proceedings.
Mayo Clin Proc, June 1999, Vol 74
Figure 1. Age at onset of the triad in 79 patients.
cal, pathological, and follow-up data were sought in the cases. Histological slides were reviewed in 71 cases (90%). RESULTS Clinical Findings Patients.—The patients were 67 women (85%) and 12 men (15%) from all continents except Africa. None was black (1 patient was erroneously reported as such43). None was related. Forty-one patients had 103 children (maximum, 9) after onset of the disorder. Age.—Age at onset (designated as the date of histological diagnosis of the first component) ranged from 7 to 48 years (Figure 1). Onset was before the age of 30 years in 65 Table 1. Presenting Symptoms and Signs Among 79 Patients* Tumors Gastric stromal sarcoma Anemia (+ or – melena) Hematemesis (+ or – melena) Serendipitous (6) or unknown Epigastric pain, nausea, vomiting Intra-abdominal or intumoral hemorrhage Asymptomatic abdominal mass Pulmonary chondroma Asymptomatic radiographically evident pulmonary mass or masses Paraganglioma Symptomatic or asymptomatic masses Hypertension
*One patient14 presented with vomiting due to an esophageal tumor (not resected). + = present; – = absent.
patients (82%) and after the age of 40 years in 5 (6%). Table 1 displays the presenting component and associated findings. Manifestations of the tumors antedated onset in 21 patients (27%) between 1 year and 26 years (mean, 6.7 years; median, 4 years). Combinations of Tumors.—Table 2 presents the tumors in the patients. At onset of the syndrome, all 3 tumors were detected in 1 patient (1%), 2 tumors in 27 (34%), and 1 tumor in 51 patients (65%). The mean interval between detection of the first and second tumors was 8.4 years (median, 6 years); the 5 longest intervals were 21, 21, 24, 24, and 26 years. The longest interval between detection of the second and third tumors was 18 years (mean, 5.9 years; median, 7 years). Other Findings.—Ten patients (13%) had nonfunctioning adrenocortical adenomas, bilateral in 1, unilateral and multifocal in 3 (Figure 2), and single in the rest. One patient had bilateral adrenal nodules that measured 12, 6, and 4 mm in diameter. Two other patients each had an unresected adrenal tumor. Seven patients (9%) had esophageal tumors that were excised in 4 patients (leiomyoma in 3, stromal tumor in 1). One unresected tumor had been present for 37 years,14 and another had not changed in size for more than 6 years.37 The tumors were asymptomatic except in 1 case.14 They were identified during endoscopic or radiographic examination for the gastric tumors. They ranged in diameter from 1 to 2 cm and occurred in the proximal, middle, and distal esophagus. Endoscopically, they were polypoid or “wormlike,” submucosal, and not ulcerated. One patient had 2 tumors, and there were probably 2 in a second patient. Seven patients had proximal duodenal stromal tumors, which were multiple in 3 patients, and 1 patient had a proximal small intestinal stromal tumor and an esophageal leiomyoma.54 Carcinoma (pulmonary, gastric [at gastroenteric anastomosis 38 years after subtotal gastrectomy], and abdominal [primary site unknown]) occurred in 3 patients. Two patients also had bony exostosis, and 1 patient each had cutaneous lipomas, bilateral ear deformity, branchial cleft cyst, renal angiomyolipoma, 2 parathyroid adenomas, gluteal myxoma and dilated cardiomyopathy, and uterine leiomyosarcoma. Gastric Stromal Sarcoma Symptoms and Signs.—The symptoms and signs are presented in Table 1. The lesion was found at surgery in 76 patients and at autopsy in 2. Location and Configuration.—Gastroscopy (24 cases) revealed 1 or more sessile, polypoid, submucosal, ulcerated masses, usually in the antrum close to the lesser curvature. Radiographic examination (35 cases) showed smooth, round or oval tumors with filling defects, generally in the distal stomach (Table 3).
Mayo Clin Proc, June 1999, Vol 74
Primary Surgery.—Subtotal gastrectomy, segmental resection(s), and total gastrectomy were performed in 50, 14, and 12 patients, respectively. Twenty-one patients (28%) had gross metastasis to 1 or more sites: gastric lymph nodes (14 patients), peritoneum (7), and liver (5). Pathological Findings.—Multiple, polypoid intramural, ulcerated tumor masses, ranging in size from 0.4 cm in diameter to 8.5 x 5.5 x 4.5 cm, were located mainly in the antrum and on the lesser curvature. Bosselated serosal masses with secondary and tertiary bleblike nodules were common. Microscopically, polygonal and fusiform cells were arranged in sheets, clusters, and fascicles. Micrometastases were found in gastric lymph nodes in 4 patients. Results of Primary Surgery.—Locally recurrent tumors developed in 23 patients (46%) after subtotal gastrectomy (in this article, “recurrent” designates a newly occurring tumor, not regrowth of a previously incompletely excised one). Among 12 patients who had segmental resection, the tumor was incompletely resected in 2, requiring additional gastric resection in 1 and total gastrectomy in the other. In 9 (90%) of the remaining 10 patients, additional tumors developed. One patient who had total gastrectomy had recurrence at the esophagoenteric anastomosis. Secondary and Tertiary Surgery.—Thirty-two patients (41%) had secondary surgery and 8 (10%) had tertiary surgery for additional gastric recurrence. The interval to recurrence ranged from 1 year to 36 years (mean, 12.4 years; median, 12 years); the longest 5 intervals were 23, 27, 28, 34, and 36 years. The interval between primary and tertiary surgery ranged from 5 to 39 years (mean, 18.8 years; median, 16.5 years). Metastasis was found in 22 patients (28%) to 1 or more intra-abdominal sites (liver, 14 patients; peritoneum, 10; gastric lymph nodes, 6), resulting in an overall rate of metastasis of 55%. Hepatic metastatic lesions were found in 1 patient 33 years after primary surgery. Two patients (3%) had extra-abdominal metastasis, to lung, bone, and skin in one and to skeletal muscle in the other; both died of the disorder. Pulmonary Chondroma Sixty patients (76%) had pulmonary chondromas, diagnosed histologically and radiologically in 45 and 15 patients, respectively. The earliest and latest ages at detection were 12 and 49 years, respectively (mean, 23.7 years; median, 21 years). A 48-year-old patient with a calcified lung nodule had normal radiographic findings at the age of 45 years. The neoplasms usually were detected during evaluation for the gastric neoplasm and often were misinterpreted as metastatic sarcoma and treated as such. Symptoms, Signs, and Radiographic Findings.—The tumors were asymptomatic, with 1 exception37: this patient
Table 2. Tumor Combinations Among 79 Patients* Gastric sarcoma
No. (%) of patients
+ + + –
+ + – +
+ – + +
17 (22) 42 (53) 19 (24) 1 (1)
*+ = present; – = absent.
had virtual replacement of a lung by confluent calcified chondromas. One tumor, multiple unilateral tumors, and bilateral tumors occurred in 31 (39%), 19 (24%), and 10 (13%) patients, respectively, without predilection for lung or lobe. Lesions were calcified initially in 27 patients (45%) and became so later in 6 patients (10%). Interpretations included metastatic neoplasm, indeterminate nodule, and pulmonary chondroma or hamartoma in 15, 13, and 7 patients, respectively. Surgery.—Forty-one patients (68%) underwent thoracotomy. The operations included tumor enucleation in 9 patients, segmental or wedge resection in 13, lobectomy in 17, and unknown procedure in 2. Eleven patients (27%) had 2 thoracotomies, and 2 (5%) had 3 for recurring chondromas. Pathological Findings.—The lung tumors were circumscribed, had a hard to soft consistency, and measured 0.5 to 12 x 10 x 10 cm. The cut surface appeared cartilaginous, bony, or gelatinous. Microscopically, a mixture of mature cartilage, bone, and stellate mesenchymal cell set in a myxoid stroma was seen. Results of Surgery.—Pulmonary surgery was curative in 18 patients (44%). Follow-up ranged from 1 year to 30 years (mean, 13.4 years; median, 13 years). One or more new tumors developed in 23 patients (56%).
Figure 2. Cut surfaces of 2 slices of adrenal gland showing a circumscribed adenoma in one and multiple small adenomas (arrows) in the other. Additional slices revealed 3 more small adenomas. Thickness of the extratumoral cortex is normal.
Mayo Clin Proc, June 1999, Vol 74
Table 3. Location of Gastric Stromal Sarcomas in 62 Patients* Location
No. (%) of patients
Antrum or lesser curvature or both Antrum, lesser curvature, body, + or – cardia Antrum, body, cardia Other combinations of locations
43 8 2 9
(69) (13) (3) (15)
*+ = present; – = absent.
Extra-adrenal Paraganglioma Thirty-seven patients (47%), ranging in age from 12 to 48 years (mean, 27.5 years; median, 27 years), had 60 paragangliomas (Table 4). Diagnosis was based on histological findings in 34 patients (92%) and on clinical, biochemical, and radiographic findings in 3 patients (8%). The latest age at discovery of a new paraganglioma (among patients who had multiple such tumors) was 61 years. Multiple sites (up to 5) were affected in 8 patients (22%). Six patients (16%) had pheochromocytoma. Metastasis occurred in 4 patients (10%). Symptoms, Signs, and Laboratory and Radiographic Findings.—Manifestations included symptoms and signs of catecholamine excess associated with increased urinary content of catecholamines and their metabolites in 13 patients, symptomatic masses in 10 patients, or asymptomatic masses (neck, mediastinal, or abdominal) in 14 patients. Lesions were localized by radiography, anTable 4. Site of Origin of 60 Paragangliomas in 34 Patients* Tumor site and type Head and neck Glomus tympanicum Glomus jugulare Glomus vagale Carotid body Larynx Thyroid Chest Superior mediastinum Aortopulmonary body Sympathetic chain Abdomen Retroperitoneum (5 para-adrenal) Adrenal Sympathetic chain Organ of Zuckerkandl Liver, porta hepatis
No. of tumors 5 2 2 8† 2 1 3 9 2 7 6‡ 9 2 2
*Diagnosis on clinical, biochemical, and radiographic findings in 3 other patients. †Bilateral in 1 patient. ‡Three had extra-adrenal paragangliomas also.
giography, computed tomography, and radioactive iodine– metaiodobenzylguanidine (131I MIBG) scintiscanning. Surgery and Other Treatment.—Thirty-one patients had 40 operations (1 patient had 5 procedures) for complete or incomplete removal of 50 separately located paragangliomas. Five patients underwent adrenalectomy (bilateral in 1). Inoperable tumors in 5 patients were treated with phenoxybenzamine hydrochloride, chemotherapy, radiation, or polyvinyl alcohol particle embolization. One patient with bilateral adrenal 131I MIBG positivity and normal results of catecholamine studies remained under study. Pathological Findings.—The tumors were firm and had a fleshy-appearing cut surface. The cells displayed eosinophilic to clear granular cytoplasm and were arranged in a trabeculoalveolar pattern supported by a fibrovascular stroma. Results of Surgery.—Forty-five paragangliomas were cured for 3 to 20 years (mean, 12 years; median, 8 years). Two patients each had secondary surgery for recurrent carotid body paraganglioma and incompletely excised aortopulmonary paraganglioma; 1 patient had reoperation for laryngeal paraganglioma and 3 operations for vertebral metastasis. Follow-up Follow-up was obtained in the 79 patients (100%), to death or to September 1997 or later. The period ranged from 1 year to 49 years (mean, 20.6 years; median, 20 years) and exceeded 30 years in 15 patients. Sixty-four patients (81%) were alive, 19 (30%) without residual tumor, for 5 to 44 years (mean, 19 years; median, 16 years) after onset. The oldest survivor was 60 years old. Forty-eight patients (61%) were alive with residual or metastatic tumors. Twenty-one patients (27%) were alive with hepatic metastatic sarcoma for 1 year to 25 years (mean, 9.3 years; median, 7 years); 4 also had recurrent gastric sarcoma, considered to have been inoperable in 2 for 12 and 15 years (Table 5). Metastatic tumors grew slowly, frequently became cystic, and were unaffected by systemic chemotherapy, radiotherapy, or hyperthermia. Hepatic metastatic lesions decreased in size spontaneously in 2 patients, following a high fever in 1, and increased by 10% during pregnancy in 1 patient. Five patients were alive, having had peritoneal spread for 1 year to 30 years (mean, 10.6 years; median, 10 years); 2 also had hepatic metastases for 5 to 16 years. Twenty-six patients were alive with pulmonary chondromas, 9 of whom had other components of the triad. Five chondromas were excised from 1 patient’s left lung at age 25 years1; 22 years later, she had 12 calcified nodules in her left and right lungs. (She also had radiographic evidence of
Mayo Clin Proc, June 1999, Vol 74
Table 5. Tumors Present at Last Follow-up in 45 of 64 Living Patients* Recurrent gastric sarcoma + +
Metastatic gastric sarcoma Liver + + + + + + +
+ + +
+ + +
+ + + +
No. of patients 1 3† 1 1 5 9‡ 1 1 1 1 1 3§ 17
*+ = present. †One also had unresected adrenal mass. ‡One also had bilateral adrenal 131I MIBG–positive tumors. §One with metastasis.
recurrent and hepatic metastatic gastric sarcoma and a 2.6cm, nonfunctioning, 131I MIBG–negative adrenal mass.) Another patient had a normal chest radiograph at the age of 18 years; 7 years later, 3 calcified lung lesions were found; another lesion developed between the ages of 25 and 27 years; at 28 years, there were 5 calcified tumors (3 on the right and 2 on the left); and 3 additional nodules were present at the age of 37 years. One patient whose lung lesions were initially detected at the age of 27 years38 had at least 6 calcified pulmonary nodules (the largest 10 cm in diameter) at the time of his death at the age of 67 years due to hepatic metastatic sarcoma. In general, the chondromas exhibited slow growth or became stable. Seven patients were alive with paraganglioma (metastatic in 1). Four additionally had combinations of residual gastric sarcoma, metastatic gastric sarcoma, and pulmonary chondroma. One patient presumed to have hepatic metastatic paraganglioma on the basis of positive findings on 131I MIBG scintiscan did not have paraganglioma elsewhere. Fifteen patients (19%) were dead, 10 (13%) of the disorder, 3 of other causes but with elements of the triad present, and 2 of causes presumably unrelated to the triad (Table 6). Pulmonary metastatic gastric carcinoma contributed to the death of 1 patient with hepatic metastatic sarcoma.56 The disorder had been present in the group for a mean of 19.6 years (median, 18 years). Family Status information was available for 118 parents, 103 children, and 136 siblings of the patients. A sibling of each
of 2 patients with gastric sarcoma and paraganglioma had bilateral carotid body paragangliomas. One of the siblings also had asymptomatic bilateral adrenal masses that were interpreted radiologically as nonfunctioning adenomas (urinary content of catecholamines and their metabolites was normal; 131I MIBG scanning had not been performed). DISCUSSION This study provides insight into the natural history of an unusual disorder, the triad of gastric stromal sarcoma, pulmonary chondroma, and paraganglioma, and shows that it is chronic, persistent, and indolent. Thus far, only 10 patients (13%) have died of causes directly attributable to the disorder, but it contributed to the deaths of 2 others, and the number of deaths doubtless will increase because 28 surviving patients (35%) have inoperable or metastatic gastric stromal sarcoma or residual or metastatic paraganglioma. Most of patients had only 2 of the 3 components. Long follow-up was required in some cases to observe development of the second component, in 1 instance 26 years. Presumably, some patients with the triad trait never manifest a second component. Key features of the gastric tumors were (1) early occurrence, (2) few local symptoms, (3) intramural origin with eventual mucosal ulceration and serosal involvement, (4) predilection for the antrum and lesser curvature, (5) multifocal occurrence with propensity for local recurrence, (6) widespread intra-abdominal metastasis, by lymphovascular and transcoelomic routes and infrequent extraabdominal spread, (7) very slow progression of metastasis, and (8) resistance of metastatic lesions to adjuvant therapy.
Mayo Clin Proc, June 1999, Vol 74
Table 6. Cause of Death Among 15 Patients With the Triad Metastatic sites
Years after onset
Liver, forearm (skeletal muscle) Liver, peritoneum … Bone (vertebra, femur) Liver, peritoneum … Liver, pleura, bone (ribs, pelvis)
34* 35 36 39 40 41
20 12 7 16 22 25
… … Liver
51 59 69
40 33 48
Cause of death Dead of disease Residual and metastatic gastric sarcoma Residual and metastatic gastric sarcoma Vagal body paraganglioma Metastatic paraganglioma Metastatic gastric sarcoma Recurrent aortopulmonary paraganglioma Metastatic gastric sarcoma and paraganglioma Metastatic gastric sarcoma and metastatic gastric carcinoma Paraganglioma, site undetermined Metastatic gastric sarcoma Dead of other cause (with disease) Postoperative complications (unresected gastric sarcoma) Metastatic abdominal adenocarcinoma, primary unknown Postoperative complications (metastatic gastric sarcoma) Subarachnoid hemorrhage (metastatic gastric sarcoma) Lung carcinoma (pulmonary chondroma)
*Partial resection of primary tumor only. †Patient had had calcified lung lesions since the age of 18 years that were never biopsied.
Initially, the sarcomas were thought to arise from smooth muscle (hence, the terms “leiomyoblastoma” and “epithelioid leiomyosarcoma”4). Because smooth muscle markers could not be consistently identified in them, they are now referred to as “gastric stromal sarcomas.” Certain of their ultrastructural features (interdigitating cell processes and dense-core granules) and immunocytochemical properties (c-kit positivity) suggest neural differentiation. The tumors may originate from precursors of the interstitial cells of Cajal.47,62 Features of the pulmonary tumors were (1) early appearance, (2) absence of symptoms, (3) absence of deleterious effects, (4) multifocal, bilateral, and peripheral occurrence, (5) coarse, often peripheral calcification, (6) benign behavior, (7) cure by surgery, and (8) propensity for development of new tumors. The chondromas were mesenchymal neoplasms, not featuring the epithelium-lined clefts characteristic of pulmonary hamartoma, the lesion with which they were commonly confused pathologically (and radiologically). Paraganglioma characteristics included (1) occurrence at a young age, (2) extra-adrenal location, with unusual sites affected (aortopulmonary body, larynx, thyroid, and possibly liver), (3) multifocality, (4) catecholamine secretion, (5) benign behavior usually, and (6) amenability to
surgical cure (location dependent) and control by other means when inoperable. The unmodified natural history of the triad was not observed, because manifestations of 2 components, the gastric sarcoma and the paraganglioma, eventually required surgical intervention. The gastric tumors were usually large at discovery. Judging by the slow growth of metastatic lesions, the primary tumors were probably present for many years before detection. In 1 patient,24 gastric surgery at the age of 20 years was preceded by intermittent epigastric pain and recurrent melena for 10 years. A patient7 with inoperable gastric sarcoma at the age of 18 years was treated with radiotherapy. Reoperation at 25 years for persisting anemia showed massive hepatic and peritoneal metastatic spread. She died of gastric hemorrhage at the age of 35 years. The findings suggest that the gastric tumors begin to develop in the first decade of life and, if left untreated, are fatal as the result of gastric hemorrhage rather than metastasis. The natural history of the paragangliomas has similarly been terminated or altered in most cases by surgical intervention, which is usually curative. The long-term outlook for inoperable tumors responding to combinations of radiation, chemotherapy, and embolization is unpredictable. A few pulmonary chondromas left in situ and observed for up to 40 years have
Mayo Clin Proc, June 1999, Vol 74
remained asymptomatic and have not caused deleterious effects. Ten patients (13%) had adrenocortical tumors. Four others each had unresected adrenal tumors, including 1 with bilateral adrenal 131I MIBG positivity. The adrenal lesions were sometimes multifocal and occasionally bilateral—the pattern of adrenal tumoral syndromic involvement. Such findings are unlikely to be happenstance, especially since adrenal nodules, even microscopic ones, are unusual in the first 3 decades of life.63 They justify acceptance of adrenocortical tumors as a component of the triad. Prior knowledge of this additional association resulted in a tentative diagnosis of the disorder in a 25-year-old Mayo Clinic patient with recurrent gastric stromal sarcomas and a 4-cm nonfunctioning adrenal mass that had been interpreted clinically as a cortical adenoma. This diagnosis was confirmed at surgery; importantly, a nonfunctioning paraaortic paraganglioma was also found, establishing the diagnosis of the triad. Intramural esophageal tumors and duodenal and proximal small intestinal tumors occurred in 7 and 8 patients, respectively. Most were histologically similar to the gastric stromal tumors, but a few of the esophageal neoplasms were leiomyomas, which merit consideration as a component of the triad. However, a precursor cell might exist with potential to differentiate along neural and smooth muscle routes, providing a possible explanation for the stromal sarcomas and the leiomyomas. If this were the case, occasional gastric tumors might prove to be leiomyomas or leiomyosarcomas rather than stromal sarcomas. (It is not logical to refer to a condition comprising 4 and possibly 5 conditions as a “triad”; this is done because of prior usage of the designation “Carney’s triad”2,20,23,27,30,31,34-38 and because the condition is referred to as the Carney triad in McKusick’s Mendelian Inheritance in Man64.) The occurrence of paragangliomas in a sibling of each of 2 unrelated patients, both of whom had gastric sarcomas and paragangliomas, also seems unlikely by chance. Components of the triad had not occurred in 355 of the primary relatives (parents, siblings, and children) of affected patients. The pattern of paraganglioma, bilateral and multifocal, in the 4 patients is that of familial paraganglioma.64 Therefore, the 2 sibships might have been exhibiting familial paraganglioma with either coincidental or specific occurrence of gastric stromal sarcomas in both. These explanations are not satisfying. Gastric stromal sarcoma has not occurred in 549 patients (290 males and 259 females) from 115 kindreds with familial paraganglioma,65-143 and the likelihood of multiple gastric stromal sarcomas and multiple paragangliomas occurring by chance in more than 1 patient seems remote. Therefore, the possibility that the triad might be familial must be considered. Familial occur-
rence (male predominance) of gastrointestinal stromal tumors, mast cell disease, and perineal hyperpigmentation has been reported144,145; neither of the latter 2 conditions was described among patients with the triad. Guidelines for the diagnostic evaluation, management, and treatment of patients with the triad are available.2 A few supplemental comments based on the findings in this study will be made. Despite the propensity for additional gastric tumors to develop in the remaining stomach, less than total gastrectomy, if feasible, is probably the best initial operation to avoid the complications of total gastrectomy, particularly in teenaged patients. Patients treated in this manner should be advised that new gastric tumors may develop and be reexamined at 3-year intervals indefinitely. For hepatic metastatic lesions of the gastric sarcomas, those that are accessible can reasonably be excised; those that are inaccessible may be amenable to chemoembolization, cryoablation, thermoablation, or a combination of these techniques; and those that produce symptoms after tumor degeneration and fluid accumulation might benefit from aspiration. Evaluation of adrenal tumors in patients with gastric stromal sarcomas or pulmonary chondromas (or both) should include study of cortical as well as medullary function. A family history should be elicited from patients with the triad and those suspected of having it (1 component of the disorder only), with attention to its components and other conditions in the family. At this time, family screening and genetic counseling for the disorder are not warranted. Lookout should be maintained for the occurrence of gastric stromal sarcomas or pulmonary chondromas in kindreds with familial paraganglioma. REFERENCES 1. 2. 3.
4. 5. 6. 7. 8.
Carney JA, Sheps SG, Go VLW, Gordon H. The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. N Engl J Med. 1977;296:1517-1518. Margulies KB, Sheps SG. Carney’s triad: guidelines for management. Mayo Clin Proc. 1988;63:496-502. Carney JA. The triad of gastric epithelioid leiomyosarcoma, pulmonary chondroma, and functioning extra-adrenal paraganglioma: a five-year review. Medicine (Baltimore). 1983;62:159169. Appelman HD, Helwig EB. Gastric epithelioid leiomyoma and leiomyosarcoma (leiomyoblastoma). Cancer. 1976;38:708-728. Jordan SM. A case of multiple leiomyosarcomata of the stomach. Surg Clin North Am. 1938;18:683-686. Lahey FH, Colcock BP. Diagnosis and surgical management of leiomyomata and leiomyosarcomata of stomach. Ann Surg. 1940;112:671-686. Fife R, Jarvie J. Leiomyosarcoma of stomach: brief review including report of case with multiple metastases. Glasgow Med J. 1952;33:490-495. Bateson EM. Cartilage-containing tumours of the lung: relationship between the purely cartilaginous type (chondroma) and the mixed type (so-called hamartoma); an unusual case of multiple tumours. Thorax. 1967;22:256-259. Dupuy R, Daumet P, Gavelle P. Association de tumeurs conjonctives pulmonaires à des tumeurs gastriques. Sem Hop Paris. 1967;43:889-893.
11. 12. 13.
17. 18. 19. 20. 21.
26. 27. 28. 29. 30.
Vio A, Abate L, Leogrande G. Considerazioni su un singolare caso di tumore gastrico a nodi multipli (leiomioma bizzarro di Stout) associato ad amartocondroma polmonare in una giovinetta di 12 anni. Ann Ital Chir. 1969;45:750-768. Bateson EM. Histogenesis of intrapulmonary and endobronchial hamartomas and chondromas (cartilage-containing tumours): a hypothesis. J Pathol. 1970;101:77-83. De Castro FJ, Olsen WR, Littler ER. Gastric leiomyoblastoma in an adolescent. Am J Surg. 1972;123:614-616. Muller M, Ryncki PV, Saegesser F, Gardiol D. Hamartomes pulmonaires multiples bilatéreaux: a propos d’une jeune femme préalablement opérée d’une tumeur musculaire de l’estomac. Schweiz Med Wochenschr. 1974;104:511-514. Lacquet LK, Moulijn AC, Jongerius CM, Limburg M, Rensing JB. Intrathoracic chemodectoma with multiple localisations. Thorax. 1977;32:203-209. Roenspies U, Morin D, Gloor E, von Hochstetter AR, Saegesser F, Senning Å. Bronchopulmonale Hamartome, Chondrome, Fibrome und Myxome. Schweiz Med Wochenschr. 1978;108: 332-339. Tisell L-E, Angervall L, Dahl I, Merck C, Zachrisson BF. Recurrent and metastasizing gastric leiomyoblastoma (epithelioid leiomyosarcoma) associated with multiple pulmonary chondrohamartomas: long survival of a patient treated with repeated operations. Cancer. 1978;41:259-265. Knake JE, Gross MD. Extraadrenal paraganglioma, pulmonary chondroma, and gastric leiomyoblastoma: triad in young females. AJR Am J Roentgenol. 1979;132:448-451. Grace MP, Batist G, Grace WR, Gillooley JF. Aorticopulmonary paraganglioma and gastric leiomyoblastoma in a young woman. Am J Med. 1981;70:1288-1292. Chander S, Oliverio R Jr, Fermon C, Chander P. Triad of neoplasms: leiomyosarcoma, functioning extra-adrenal tumors, and pulmonary chondroma. N Y State J Med. 1981;81:392-393. Dajee A, Dajee H, Hinrichs S, Lillington G. Pulmonary chondroma, extra-adrenal paraganglioma, and gastric leiomyosarcoma: Carney’s triad. J Thorac Cardiovasc Surg. 1982;84:377-381. Baril A, Boucheron S, Cuilleret J, Pichon A, Serpentié P. Association d’une tumeur myoïde de l’estomac et d’un paragangliome extrasurrénalien fonctionnel: une nouvelle observation en faveur de l’individualisation d’un syndrome. Arch Anat Cytol Pathol. 1982;30:185-189. McGahan JP. Carney syndrome: usefulness of computed tomography in demonstrating pulmonary chondromas. J Comput Assist Tomogr. 1983;7:137-139. Chahinian AP, Kirschner PA, Dikman SH, Rammos KS, Holland JF. Pulmonary metastatic leiomyosarcoma coexisting with pulmonary chondroma in Carney’s triad. Arch Intern Med. 1983; 143:1462-1464. Xu CP, Li GY, Liao FQ, Hong DL, Liu WW. Gastric leiomyoblastoma with multiple pulmonary chondrohamartomas: a case report. Chin Med J (Engl). 1983;96:367-369. Sawai T, Ikeda T, Ito S, et al. Case of three peculiar tumors of gastric epithelioid leiomyosarcoma, retroperitoneal paraganglioma and pulmonary chondroma [in Japanese]. Gan No Rinsho. 1983;29:177-182. Lacquet LK, Jongerius CM, Limburg M, Rensing JB. La triade: chémodectome du médiastin, chondrome du poumon et léiomyome de l’oesophage. Rev Pneumol Clin. 1984;40:63-67. Cuilleret J, Baril A, Boucheron S, Pichon A, Serpantie P. La triade de Carney. Presse Med. 1984;13:79-82. Bigotti G, Lopez M. Concomitanza di leiomiosarcoma epitelioide gastrico, paraganglioma extrasurrenalico funzionale e condroma del polmone. Clin Ter. 1984;110:271-275. Cueto-Garcia L, Shub C, Sheps SG, Puga FJ. Two-dimensional echocardiographic detection of mediastinal pheochromocytoma. Chest. 1985;87:834-836. Rüfenacht H, Mihatsch MJ, Jundt K, Gächter A, Tanner K, Heitz PU. Gastric epithelioid leiomyomas, pulmonary chondroma, nonfunctioning metastasizing extra-adrenal paraganglioma and myxoma: a variant of Carney’s triad; report of a patient. Klin Wochenschr. 1985;63:282-284.
Mayo Clin Proc, June 1999, Vol 74
38. 39. 40. 41. 42. 43.
45. 46. 47.
49. 50. 51. 52.
Mishkin FS, Vasinrapee P, Vora L, Bier R, Mackabee JR. Carney’s triad: radiographic diagnosis, natural history and importance of pulmonary chondromas. J Can Assoc Radiol. 1985;36: 264-266. Walker P, Dvorak AM. Gastrointestinal autonomic nerve (GAN) tumor: ultrastructural evidence for a newly recognized entity. Arch Pathol Lab Med. 1986;110:309-316. Segal A, Carello S, Caterina P, Papadimitriou JM, Spagnolo DV. Gastrointestinal autonomic nerve tumors: a clinicopathological, immunohistochemical and ultrastructural study of 10 cases. Pathology. 1994;26:439-447. Raafat F, Salman WD, Roberts K, Ingram L, Rees R, Mann JR. Carney’s triad: gastric leiomyosarcoma, pulmonary chondroma and extra-adrenal paraganglioma in young females. Histopathology. 1986;10:1325-1333. Tortella BJ, Matthews JB, Antonioli DA, Dvorak AM, Silen W. Gastric autonomic nerve (GAN) tumor and extra-adrenal paraganglioma in Carney’s triad: a common origin. Ann Surg. 1987; 205:221-225. McLaughlin SJ, Dodge EA, Ashworth J, Connors J. Carney’s triad. Aust N Z J Surg. 1988;58:679-681. Mazas-Artasona L, Romeo M, Felices R, et al. Gastroœsophageal leiomyoblastomas and multiple pulmonary chondromas: an incomplete variant of Carney’s triad. Br J Radiol. 1988;61:1181-1184. Evans RA, Salisbury JR, Gimson A, Michell MJ. Indolent gastric epithelioid leiomyosarcoma in Carney’s triad. Clin Radiol. 1990;42:437-439. Tossou H, Delamarre J, Sevestre H, Deschepper B, Jouet-Gondry C, Capron JP. Syndrome de Carney révélé par un hémoperitoine. Gastroenterol Clin Biol. 1990;14:394-398. Beigelman C, Perez T, Rémy-Jardin M, Ribet M, Rémy J. La triade de Carney: l’imagerie dans le diagnostic et la surveillance. Rev Im Med. 1990;2:171-177. Le Blanc I, Laurent M, Bokobza B, Michot F, Teniere P. Triade de Carney: un nouveau cas associé à un adénome corticosurrénalien. Gastroenterol Clin Biol. 1990;14:399-401. Cardwell RJ, Solaiman AR, Kim K, Thomford NR. Carney’s triad with recurrent gastric leiomyoblastoma. Am Surg. 1990;56: 355-359. Khafagi FA, Shapiro B, Fischer M, Sisson JC, Hutchinson R, Beierwaltes WH. Phaeochromocytoma and functioning paraganglioma in childhood and adolesence: role of iodine 131 metaiodobenzylguanidine. Eur J Nucl Med. 1991;18:191-198. Persson S, Kindblom LG, Angervall L, Tisell LE. Metastasizing gastric epithelioid leiomyosarcomas (leiomyoblastomas) in young individuals with long-term survival. Cancer. 1992;70:721732. Blei E, Gonzalez-Crussi F. The intriguing nature of gastric tumors in Carney’s triad: ultrastructural and immunohistochemical observations. Cancer. 1992;69:292-300. Barcena R, Erdozain JC, San Román AL, García M, Boixeda D, Pérez FA. Tríada de Carney: breve revisión a propósito de un caso. Rev Clin Esp. 1992;190:410-412. Perez-Atayde AR, Shamberger RC, Kozakewich HWP. Neuroectodermal differentiation of the gastrointestinal tumors in the Carney triad: an ultrastructural and immunohistochemical study. Am J Surg Pathol. 1993;17:706-714. Argos MD, Ruiz A, Sanchez F, Garcia C, Gaztambide J. Gastric leiomyoblastoma associated with extraadrenal paraganglioma and pulmonary chondroma: a new case of Carney’s triad. J Pediatr Surg. 1993;28:1545-1549. Fernández Aguilar JR, López Rueda B, Santoyo Santoyo J, et al. Triada de Carney: leiomiosarcoma gástrico recidvado. Cirug Esp. 1993;54:352-354. Acha T, Picazo B, Garciá-Martín FJ, Urda A, Campos J. Carney’s triad: a propos of a new case. Med Pediatr Oncol. 1994;22:216-220. Prayag AK, Vora IM, Antani RD, Shenoy S. Carney’s triad with twin lesions. Indian J Gastroenterol. 1993;12:61. Erb RE, Delbeke D, Falke THM, Sandler MP. Magnetic resonance imaging of Carney’s triad. South Med J. 1994;87:951-955.
Schmutz GR, Fisch-Ponsot C, Sylvestre J. Carney syndrome: radiologic features. Can Assoc Radiol J. 1994;45:148-150. Iuchi K. Carney’s triad. Ryoikibetsu Shokogun Shirizu. 1994; 4:687-690. Kawamura M, Takahashi Y, Sakata Y. Carney’s triad with gastric leiomyosarcoma and multiple hamartomas: a case report [in Japanese]. J Jap Assoc Chest Surg. 1994;8:190-195. Aulicino MR, Hytiroglou P, Dikman SH, Kaneko M. Gastric stump carcinoma occurring in a patient with Carney’s triad 38 years after partial gastrectomy for epithelioid leiomyosarcoma [letter]. Arch Intern Med. 1995;155:544, 547. Amoroso A, Pasquarelli C, Di Rosa R, Paggi A, Addessi MA. Associazione feocromocitoma-leiomioblastoma gastrico: possibile expressione di triade di Carney; un caso di nostra osservazione. Recenti Prog Med. 1995;86:348-352. Majerus B, Dekoninck X, Debongnie JC, Machiels J, Bleeckx AF, Wibin E. Syndrome de Carney: deux nouveaux cas. Ann Chir. 1996;50:470-473. Salgado M, Galán MC, Pelegrí A, Ribé A, Grau JJ. Carney’s triad: incomplete presentation of a patient with gastric leiomyosarcoma and extra-adrenal paraganglioma. Neoplasia. 1996; 13:182-185. de Jong E, Mulder W, Nooitgedacht E, Taat CW, Bras J. Carney’s triad. Eur J Surg Oncol. 1998;24:147-149. Lamovec J, Frkovic-Grazio S, Bracko M. Nonsporadic cases and unusual morphological features in pheochromocytoma and paraganglioma. Arch Pathol Lab Med. 1998;122:63-68. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577-580. Carney JA. Adrenal gland. In: Sternberg SS, ed. Histology for Pathologists. 2nd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1997:1107-1131. McKusick VA. Mendelian Inheritance in Man: A Catalog of Human Genes and Genetic Disorders. Vol 1. 11th ed. Baltimore, Md: The Johns Hopkins University Press; 1994:1093. Entry 168000. Chase WH. Familial and bilateral tumours of carotid body. J Pathol Bacteriol. 1933;36:1-12. Sprong DH Jr, Kirby FG. Familial carotid body tumors: report of 9 cases in 11 siblings. Ann West Med Surg. 1949;3:241-242. Lewison EF, Weinberg T. Carotid body tumors: case report of bilateral carotid body tumors with unusual family incidence. Surgery. 1950;27:437-448. Desai MG, Patel CC. Heredo-familial carotid body tumors. Clin Radiol (Lond). 1961;12:214-218. van der Borden J. Bilateral non-chromaffin tympano-jugular paraganglioma. J Laryngol Otol. 1967;81:445-448. Ladenheim JC, Sachs E Jr. Familial tumors of the “glomus jugulare”: report of 2 cases, with a note on the vascular origin of the glomera. Neurology. 1961;11:303-309. Rush BF Jr. Familial bilateral carotid body tumors. Ann Surg. 1963;157:633-636. Katz AD. Carotid body tumors in a large family group. Am J Surg. 1964;108:570-573. Kroll AJ, Alexander B, Cochios F, Pechet L. Hereditary deficiencies of clotting factors VII and X associated with carotid-body tumors. N Engl J Med. 1964;270:6-13. Farr HW. Carotid body tumors: a thirty year experience at Memorial Hospital. Am J Surg. 1967;114:614-619. Del Fante FM, Watkins E Jr. Chemodectoma of the heart in a patient with multiple chemodectomas and familial history: case report and survey of literature. Lahey Clin Found Bull 1967;16:224-229. Beard M, McQuarrie DG. Brotherly lumps: familial occurrence of chemodectoma. Minn Med. January 1968;51:79-82. Piaget F, Charachon R, Barge M, Gros JC, Junien-Lavillauroy C. A propos de deux observations de tumeur du glomus carotidien: dont un cas familial associé à une tumeur du glomus jugulaire. Ann Otolaryngol Chir Cervicofac. 1968;85:181-188. Ribet M, Deminatti M, Desaulty-Cousin A, Meignié P. Tumeurs du glomus carotidien et maladie glomique familiale. Presse Med. 1969;77:1043-1046.
79. 80. 81. 82.
83. 84. 85.
89. 90. 91. 92.
93. 94. 95. 96.
97. 98. 99. 100.
Sugarbaker EV, Chretien PB, Jacobs JB. Bilateral familial carotid body tumors: report of a patient with an occult contralateral tumor and postoperative hypertension. Ann Surg. 1971;174:242-247. Pratt LW. Familial carotid body tumors. Arch Otolaryngol. 1973;97:334-336. Boon CM. Twee families met glomustumoren. Ned Tijdschr Geneeskd. 1976;120:505-512. Kahn LB. Vagal body tumor (nonchromaffin paraganglioma, chemodectoma, and carotid body-like tumor) with cervical node metastasis and familial association: ultrastructural study and review. Cancer. 1976;38:2367-2377. Lee SP, Nicholson GI, Hitchcock G. Familial abdominal chemodectomas with associated cutaneous angiolipomas. Pathology. 1977;9:173-177. Schmidt FE, Lewis ML Jr, Kahle HR. Chemodectomas of the carotid body and glomus tympanicum: sequential occurrence in sisters. JAMA. 1978;240:1266-1267. Bogdasarian RS, Lotz PR. Multiple simultaneous paragangliomas of the head and neck in association with multiple retroperitoneal pheochromocytomas. Otolaryngol Head Neck Surg. 1979;87:648-652. Rose KG, Jahnke K, Galanski M. Die tumoren des Glomus caroticum und des Glomus vagale: Eine Darstellung von 24 einschlisslich familiär gehäufter und bilateraler Tumoren. HNO. 1979;27:192-200. Grufferman S, Gillman MW, Pasternak LR, Peterson CL, Young WG Jr. Familial carotid body tumors: case report and epidemiologic review. Cancer. 1980;46:2116-2122. Veldman JE, Mulder PH, Ruijs SH, de Haas G, van Waes PF, Hoekstra A. Early detection of asymptomatic hereditary chemodectoma with radionuclide scintiangiography: a possibility for family screening and surveillance. Arch Otolaryngol. 1980;106: 547-552. Pereira DT, Hunter RD. Familial multicentric non-chromaffin paragangliomas: a case report on a patient with glomus jugulare and bilateral carotid body tumours. Clin Oncol. 1980;6:273-275. Verhulst J, Portmann M, Boissiéras P, Deminière C, Piton J. Chémodectome bilatéral, malin, familial, chez une jeune fille de 16 ans. Rev Laryngol Otol Rhinol (Bord). 1980;101:251-261. Coia LR, Fazekas JT, Farb SN. Familial chemodectoma. Int J Radiat Oncol Biol Phys. 1981;7:949-952. van Baars FM, Cremers CW, van den Broek P, Veldman JE. Familiar non-chromaffinic paragangliomas (glomus tumors): clinical and genetic aspects (abridged). Acta Otolaryngol (Stockh). 1981;91:589-593. Parkin JL. Familial multiple glomus tumors and pheochromocytomas. Ann Otol Rhinol Laryngol. 1981;90:60-63. Pritchett JW. Familial concurrence of carotid body tumor and pheochromocytoma. Cancer. 1982;49:2578-2579. Parry DM, Li FP, Strong LC, et al. Carotid body tumors in humans: genetics and epidemiology. J Natl Cancer Inst. 1982;68: 573-578. Larraza-Hernandez O, Albores-Saavedra J, Benavides G, Krause LG, Perez-Merizaldi JC, Ginzo A. Multiple endocrine neoplasia: pituitary adenoma, multicentric papillary thyroid carcinoma, bilateral carotid body paraganglioma, parathyroid hyperplasia, gastric leiomyoma, and systemic amyloidosis. Am J Clin Pathol. 1982;78:527-532. Bleker RJ, Wereldsma JC. Carotid body tumor: familial occurrence. Neth J Surg. 1986;38:76-80. Miccoli P, Iacconi P, Roncella M, Arganini M. Tumeur du glomus carotidien: présentation d’un cas familial. Acta Chir Belg. 1986;86:159-162. Mikhail RA, Moore JB, Reed DN Jr, Abbott RR. Malignant retroperitoneal paragangliomas. J Surg Oncol. 1986;32:32-36. Khafagi F, Egerton-Vernon J, van Doorn T, Foster W, McPhee IB, Allison RW. Localization and treatment of familial malignant nonfunctional paraganglioma with iodine-131 MIBG: report of two cases. J Nucl Med. 1987;28:528-531. Santini J, Batt M, Dassonville O, et al. Paragangliomes de la tête et du cou: formes familiales. Ann Otolaryngol Chir Cervicofac. 1989;106:589-592.
104. 105. 106. 107. 108. 109.
110. 111. 112. 113.
114. 115. 116. 117. 118.
Sebastian JP, Williams SE, Wells M, Peake MD. Familial malignant retroperitoneal paraganglioma. Postgrad Med J. 1989;65: 781-784. van der Mey AG, Maaswinkel-Mooy PD, Cornelisse CJ, Schmidt PH, van de Kamp JJP. Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet. 1989;2:12911294. Giron J, Joffre P, Sénac JP, Castan P. Paragangliome du vague associé à une malformation rare de la crosse aortique: a propos d’un cas et revue de la littérature. J Radiol. 1989;70:477-481. Barnes L, Taylor SR. Carotid body paragangliomas: a clinicopathologic and DNA analysis of 13 tumors. Arch Otolaryngol Head Neck Surg. 1990;116:447-453. Granger JK, Houn HY. Bilateral familial carotid body paragangliomas: report of a case with DNA flow cytometric and cytogenetic analyses. Arch Pathol Lab Med. 1990;114:1272-1275. Shedd DP, Arias JD, Glunk RP. Familial occurrence of carotid body tumors. Head Neck. 1990;12:496-499. Sobol SM, Dailey JC. Familial multiple cervical paragangliomas: report of a kindred and review of the literature. Otolaryngol Head Neck Surg. 1990;102:382-390. Le Bodic MF, Fiche M, Aillet G, et al. Immunohistochemical study of 6 multiple familial cervical paragangliomas with lymph node metastasis in one case [in French]. Ann Pathol. 1991;11: 176-180. Tali ET, Sener RN, Ibis E, Alper H, Ariyurek M. Familial bilateral glomus jugulare tumors. Neuroradiology. 1991;33:171-172. Jensen JC, Choyke PL, Rosenfeld M, et al. A report of familial carotid body tumors and multiple extra-adrenal pheochromocytomas. J Urol. 1991;145:1040-1042. Ophir D. Familial multicentric paragangliomas in a child. J Laryngol Otol. 1991;105:376-380. van Gils AP, van der Mey AG, Hoogma RP, et al. MRI screening of kindred at risk of developing paragangliomas: support for genomic imprinting in hereditary glomus tumours. Br J Cancer. 1992;65:903-907. Brandwein M, Levi G, Som P, Urken ML. Paraganglioma of the inferior laryngeal paraganglia: a case report. Arch Otolaryngol Head Neck Surg. 1992;118:994-996. Borowy ZJ, Probst L, Deitel M, Shankar L. A family exhibiting carotid body tumours. Can J Surg. 1992;35:546-551. Tali ET, Yuh WT, Mayr NA, Nguyen H, Gao F, Dolan KD. Magnetic resonance imaging of bilateral familial paragangliomas. Ann Otol Rhinol Laryngol. 1993;102:473-477. Ridge BA, Brewster DC, Darling RC, Cambria RP, LaMuraglia GM, Abbott WM. Familial carotid body tumors: incidence and implications. Ann Vasc Surg. 1993;7:190-194. Mariman EC, van Beersum SE, Cremers CW, van Baars FM, Ropers HH. Analysis of a second family with hereditary nonchromaffin paragangliomas locates the underlying gene at the proximal region of chromosome 11q. Hum Genet. 1993;91:357361. Mena J, Bowen JC, Hollier LH. Metachronous bilateral nonfunctional intercarotid paraganglioma (carotid body tumor) and functional retroperitoneal paraganglioma: report of a case and review of the literature. Surgery. 1993;114:107-111. McCaffrey TV, Meyer FB, Michels VV, Piepgras DG, Marion MS. Familial paragangliomas of the head and neck. Arch Otolaryngol Head Neck Surg. 1994;120:1211-1216. Hughes-Davies L, Mannarino E, Alexander E III, Kooy H, Loeffler JS. Technical modifications required to treat cervical chemodactomas with stereotactic radiosurgery. Surg Neurol. 1994;41:418-420. Murphy GF, Miller SD, Kenady DE, et al. Familial paraganglioma. Urology. 1994;44:273-277. Zaslav AL, Myssiorek D, Mucia C, Fox JE. Cytogenetic analysis of tissues from patients with familial paragangliomas of the head and neck. Head Neck. 1995;17:102-107.
Mayo Clin Proc, June 1999, Vol 74
124. 125. 126. 127. 128. 129. 130.
131. 132. 133. 134. 135. 136.
138. 139. 140.
142. 143. 144.
Wang DG, Barros D’Sa AA, Johnston CF, Buchanan KD. Oncogene expression in carotid body tumors. Cancer. 1996;77: 25812587. Gardner P, Dalsing M, Weisberger E, Sawchuk A, Miyamoto R. Carotid body tumors, inheritance, and a high incidence of associated cervical paragangliomas. Am J Surg. 1996;172:196-199. Wharton SM, Davis A. Familial paraganglioma. J Laryngol Otol. 1996;110:688-690. Nakada J, Oishi Y, Onodera S, et al. A case of ectopic familial pheochromocytoma [in Japanese]. Nippon Hinyokika Gakkai Zasshi. 1996;87:1060-1063. Linn HJ, Proctor B. Tumor of the ganglion nodosum of the vagus nerve. Laryngoscope. 1956;66:1577-1581. Milanesi U, Mangili F, Milanesi I. Studio citofluorimetrico di paragangliomi familiari del corpo carotideo. Acta Otorhinolaryngol Ital. 1994;14:439-447. Struycken PM, Cremers CW, Mariman EC, Joosten FB, Bleker RJ. Glomus tumours and genomic imprinting: influence of inheritance along the paternal or maternal line. Clin Otolaryngol. 1997;22:71-76. Gardner PA, Miyamoto RG, Shah MV, Righi PD, Timmerman RD. Malignant familial glomus jugulare and contralateral carotid body tumor. Am J Otolaryngol. 1997;18:269-273. Whiteman ML, Serafini AN, Telischi FF, Civantos FJ, Falcone S. 111 In octreotide scintigraphy in the evaluation of head and neck lesions. AJNR Am J Neuroradiol. 1997;18:1073-1080. Milunsky J, DeStefano AL, Huang XL, et al. Familial paragangliomas: linkage to chromosome 11q23 and clinical implications. Am J Med Genet. 1997;72:66-70. Baysal BE, Farr JE, Rubinstein WS, et al. Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23. Am J Hum Genet. 1997;60:121-132. Myssiorek D, Palestro CJ. 111Indium pentetreotide scan detection of familial paragangliomas. Laryngoscope. 1998;108:228-231. Sköldberg F, Grimelius L, Woodward ER, et al. A family with hereditary extra-adrenal paragangliomas without evidence for mutations in the von Hippel-Lindau disease or ret genes. Clin Endocrinol (Oxf). 1998;48:11-16. Blay L, Basterra J, Marco Algarra J, Palop JM, Pellin A. Glomus carotideo bilateral y yugular unilateral familiar: estudio ultrastructural a propósito de dos casos clínicos. An Otorrinolaringol Ibero Am. 1985;12:209-215. Yagi A, Takahashi H, Yao K, Sano H, Nitta K. The two cases of carotid body tumor in the same family [in Japanese]. Nippon Jibiinkoka Gakkai Kaiho. 1988;91:1987-1995. Geysens P, D’Haenens P, Van Steenberge R, Wilms G, Baert AL. Familial occurrence of paragangliomas. J Belge Radiol. 1989; 72:95-99. Heutink P, van Schothorst EM, van der Mey AG, et al. Further localization of the gene for hereditary paragangliomas and evidence for linkage in unrelated families. Eur J Hum Genet. 1994;2:148-158. van Schothorst EM, Jansen JC, Bardoel AF, et al. Confinement of PGL, an imprinted gene causing hereditary paragangliomas, to a 2-cM interval on 11q22-q23 and exclusion of DRD2 and NCAM as candidate genes. Eur J Hum Genet. 1996;4:267-273. Cimino DA. Paraganglioma timpano-giuglare bilaterale a carattere familiare. Valsalva. 1965;41:204-222. Marchesi M, Biffoni M, Tartaglia F, et al. I paragangliomi nella casistica dell’istituto di III Clinica Chirurgica (1970-1995). G Chir. 1997;18:615-618. Marshall JB, Diaz-Arias AA, Bochna GS, Vogele KA. Achalasia due to diffuse esophageal leiomyomatosis and inherited as an autosomal dominant disorder: report of a family study. Gastroenterology. 1990;98:1358-1365. Nishida T, Hirota S, Taniguchi M, et al. Familial gastrointestinal stromal tumours with germline mutation of the KIT gene [letter]. Nat Genet. 1998;19:323-324.